Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Ajanta Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:532331NSE Symbol: AJANTPHARMP/E(TTM):34.04
ISIN Demat:INE031B01049Div & Yield %:1.1EPS(TTM):74.9
Book Value(Rs):290.1676063Market Cap ( Cr.):31853.59Face Value(Rs):2
    Change Company 
Date Headline
08-Sep-25 Ajanta Pharma Ltd - Ajanta Pharma Limited - Copy of Newspaper Publication
04-Sep-25 Ajanta Pharma Ltd up for third straight session
02-Sep-25 Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
02-Sep-25 Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
26-Aug-25 Ajanta Pharma Ltd drops for fifth straight session
21-Aug-25 Ajanta Pharma Ltd - Ajanta Pharma Limited - Updates
05-Aug-25 Ajanta Pharma Ltd down for fifth straight session
31-Jul-25 Ajanta Pharma Ltd - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
29-Jul-25 Ajanta Pharma Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
28-Jul-25 Ajanta Pharma allots 23,525 equity shares under ESOP
<< < 1 2 3 4   > >>